KPV 5 mg

Beschreibung

KPV (Lys-Pro-Val) is a naturally occurring three-amino-acid fragment of α-melanocyte-stimulating hormone (α-MSH). Despite its small size, it retains much of the parent hormone’s anti-inflammatory activity while lacking the pigmentation effects associated with full-length α-MSH.

Unlike many immune-modulating peptides, KPV appears to regulate inflammatory signalling without broadly suppressing immune function. This has made it one of the most interesting investigational peptides for research involving inflammatory diseases, epithelial barrier function and mucosal immunity.

Why KPV is widely investigated

Published research has investigated KPV in relation to:

• immune regulation
• entzündliche Signalübertragung
• gut health research
• intestinal barrier function
• skin inflammation
• epithelial biology
• Wundheilung
• mucosal immunity
• NF-κB signalling

Because of its small size and unique mechanism, KPV has become one of the best-known research peptides targeting inflammatory pathways rather than structural tissue repair.

How KPV works

Unlike BPC-157 or TB-500, KPV is primarily investigated for its effects on immune signalling rather than tissue regeneration.

Veröffentlichte Forschung hat dessen Zusammenhang untersucht mit:

Inflammatory signalling

KPV has been widely investigated for its ability to reduce activation of inflammatory pathways including NF-κB, resulting in lower production of multiple pro-inflammatory mediators in experimental models.

Gut barrier research

One of the largest areas of investigation focuses on intestinal epithelial cells and experimental models of inflammatory bowel disease, where KPV has demonstrated effects on epithelial integrity and inflammatory signalling.

Skin biology

Researchers have also explored KPV in models of inflammatory skin conditions and wound repair because of its effects on epithelial tissues.

Immunmodulation

Current evidence suggests that KPV modulates immune responses rather than producing broad immunosuppression, making it an interesting candidate for studies of physiological inflammatory regulation.

Why KPV is becoming increasingly important

Interest in KPV has increased significantly over the last several years because it represents a different approach to inflammation research.

Rather than focusing primarily on structural tissue repair like BPC-157 or systemic regeneration like TB-500, KPV investigates the signalling pathways that initiate and maintain inflammation.

This complementary biology has made KPV increasingly popular in research involving inflammatory bowel disease, skin biology and epithelial barrier function.

Menschliche und präklinische Forschung

Most published evidence for KPV comes from cell culture and animal models.

Research has consistently investigated inflammatory signalling in the gut, skin, lungs and epithelial tissues, while human clinical evidence remains limited. Although the preclinical data are encouraging, additional human research is required before conclusions can be drawn regarding clinical applications.

Veröffentlichte Sicherheitsbeobachtungen

Current knowledge of KPV is derived predominantly from laboratory and preclinical research. Published studies generally report favourable tolerability in experimental models, but controlled human clinical evidence remains limited. As with many emerging research peptides, additional studies are needed to fully characterise long-term efficacy and safety.

Produkteigenschaften

Anwendung: Labor- und analytische Forschung
Verwendungseinschränkung: Nicht zum menschlichen Verzehr bestimmt; nicht für medizinische, veterinärmedizinische oder kosmetische Zwecke
Hergestellt in GMP-konformen Anlagen unter strengen Qualitätskontrollprotokollen.
Jede Charge wird nach der Produktion sorgfältig im Labor getestet (das Analysezertifikat finden Sie unter den Produktbildern).
Gefriergetrocknet (lyophilisiert) für maximale Stabilität und längere Haltbarkeit.
Steril in Fläschchen abgefüllt, bereit zur Rekonstitution.
Reinheit: ≥99,1 % (HPLC-geprüft)
Aussehen: Lyophilisiertes weißes/weißliches Pulver
Summenformel: C₁₆H₃₀N₄O₄
Molekulargewicht: 342,43
Lys-Pro-Val
Lagerung: Ungeöffnete lyophilysierte Fläschchen werden am besten gekühlt bei 2–8 °C gelagert, was die von unserem Produktionspartner bestätigte Lagerungsmethode ist und für bis zu 24 Monate geeignet ist. Kühlung wird bevorzugt, da sie unnötige Gefrier-Tau-Zyklen bei der routinemäßigen Handhabung minimiert. Wenn eine wesentlich längerfristige Lagerung erforderlich ist, können ungeöffnete lyophilysierte Fläschchen auch gefroren aufbewahrt werden. Nach der Rekonstitution immer bei 2–8 °C lagern und nicht einfrieren.

Rekonstitution und Handhabung

KPV  is supplied as a lyophilised vial and should be handled using standard peptide reconstitution procedures appropriate to the research setting. Must be reconstituted with Bakteriostatisches Wasser Vor Gebrauch. Um die strukturelle Integrität zu erhalten, geben Sie das gewählte Lösungsmittel langsam an der Innenwand des Fläschchens hinzu und nicht direkt auf den Peptidkuchen, und vermeiden Sie kräftiges Schütteln. Sanftes Schwenken ist im Allgemeinen ausreichend, sobald sich das Peptid vollständig gelöst hat. Standardmäßige Laborpraxis beinhaltet auch, gekühlte Fläschchen Raumtemperatur erreichen zu lassen, bevor sie rekonstituiert werden, um die Kondensation im Fläschchen zu minimieren.

Für weitere Informationen zur Lösungsmittelauswahl, zur Konzentrationsplanung und zur Lagerung siehe das vollständige Leitfaden zur Peptidrekonstitution und Rekonstitutionsrechner.

Ausgewählte Referenzen

• Dalmasso G, et al. PepT1-Mediated Uptake of the Tripeptide KPV Reduces Intestinal Inflammation, Molecular Therapy, 2011

A landmark study demonstrating epithelial uptake of KPV and reduced inflammatory signalling in experimental intestinal inflammation.

• Kannengiesser K, et al. KPV Protects Against Experimental Colitis Through Modulation of Inflammatory Pathways, Gastroenterology Research, 2017

Research demonstrating protective effects of KPV in experimental inflammatory bowel disease models.

• Brzoska T, Luger TA, et al. Alpha-MSH and the C-Terminal Tripeptide KPV in Inflammation, Journal of Investigative Dermatology, 2003

A foundational review explaining why the KPV fragment retains potent anti-inflammatory activity despite lacking the full α-MSH sequence.

• Merlin D, et al. KPV and Epithelial Immune Regulation, Various publications

A series of studies exploring KPV transport through PepT1 and regulation of epithelial inflammatory signalling.

Häufig gestellte Fragen

What is KPV?

KPV is a naturally occurring tripeptide derived from α-melanocyte-stimulating hormone (α-MSH). It is widely investigated for immune regulation, inflammatory signalling and epithelial barrier research.

Why is KPV different from BPC-157?

Although both peptides are frequently discussed in recovery research, BPC-157 is primarily investigated for tissue repair, whereas KPV focuses on immune regulation and inflammatory signalling. Their biological targets are complementary rather than identical.

Why is KPV associated with gut health research?

Much of the published literature has investigated KPV in intestinal epithelial cells and experimental models of inflammatory bowel disease because of its effects on inflammatory signalling and epithelial barrier function.

What research areas commonly investigate KPV?

Current research includes immune regulation, gut inflammation, epithelial biology, wound healing, skin inflammation, mucosal immunity and inflammatory signalling.

Does KPV work through melanocortin receptors?

Current evidence suggests that many of KPV’s anti-inflammatory effects occur independently of classical melanocortin receptor signalling, making it mechanistically distinct from full-length α-MSH.

Ist dieses Produkt für den menschlichen Gebrauch bestimmt?

No. KPV supplied by LIFE Peptide is provided strictly for laboratory and analytical research. It is not intended for human consumption, diagnosis, treatment or prevention of disease. Any discussion of published studies summarises the scientific literature relating to the KPV molecule rather than the intended use of this product.

Verwandter Forschungskontext

KPV gehört zur Heilungs- und Erholungspeptid-Forschung Kategorie, with a stronger focus on inflammatory signaling and epithelial pathway investigation. KPV is frequently discussed alongside other research peptides investigating immune regulation, tissue repair and recovery:

BPC-157 – investigated primarily for tissue repair, tendon biology and angiogenesis.
TB-500 (Thymosin β4) – studied for cell migration, regeneration and wound healing.
Glow Blend – combines GHK-Cu, BPC-157 and TB-500 for multi-pathway recovery research.
Wolverine Mischung – combines BPC-157 and TB-500 for connective tissue and regeneration studies.
GHK-Cu – investigated in skin biology, extracellular matrix remodelling and wound repair.

Although these peptides are often grouped within recovery research, KPV stands apart by focusing primarily on immune regulation and inflammatory signalling rather than structural tissue regeneration.
Für breiteren Kontext siehe die Leitfaden für Forschung zu Heilung und Genesung.

HINWEIS: Dies dient nur zu Bildungszwecken und stellt keine medizinische Beratung dar.

Haftungsausschluss
Dieses Produkt wird ausschließlich zu Forschungszwecken verkauft. Es ist nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Der Käufer übernimmt die volle Verantwortung für die ordnungsgemäße Handhabung und Verwendung.